Bill Ackman And Valeant: A Play In Two PowerPoint Slides

This might be Pershing Square's finest work yet.
Author:
Updated:
Original:

Tucked within the 86 pages of Pershing Square's annual presentation for European investors published Monday were just two devoted to the investment that was Bill Ackman's albatross: Valeant Pharmaceuticals. As recently as January, Ackman was waxing eloquent (in PowerPoint form) about “creating the new Valeant.” Then last month he abruptly parted ways with the company, losing only his dignity and around $4 billion in the process.

Bill ackman beach

One would think that such a whirlwind experience would inspire some verbosity from Ackman, who is rarely short on words. Yet in the new presentation we get only two short slides on the Valeant affair. This doesn't blunt their impact, however. Like a poet, Ackman has condensed the Valeant story into its base elements, omitting everything ancillary and inessential. What remains is a quietly stirring testament to one man's stubborn devotion to his ideals. Behold:

Screen Shot 2017-04-24 at 1.15.06 PM
Screen Shot 2017-04-24 at 1.15.14 PM

That's it!

Related

Bill ackman beach

Bill Ackman: Extremely Bullish On Trump And “Long America” (Excepting Valeant)

Ackman's come a long way from mocking the size of Trump‘s bank account.

Bill ackman beach

Bill Ackman Wants The World To Know How Hard It Is Being Bill Ackman

The ADP-Pershing Square battle is going about as expected.

Bill Ackman Not Worried About Valeant In The Slightest

The Pershing Square manager is cool as a cucumber despite the whole 'huge losses' thing.

Bill ackman beach

Bill Ackman Had An Epiphany

The eureka moment: "I need to make money."

Bill ackman beach

Looks Like ADP May Not Be Bill Ackman's Next Chipotle After All

Though if it's any consolation, at least ADP won't make him violently ill.

Bill Ackman Doesn't Think Valeant's Awesomeness Has Been Adequately Conveyed

There's simply no other way to explain what's happening there.